Elucent Medical

Executive Summary

Elucent Medical is a private medical device company headquartered in Minneapolis, MN, focused on enhancing surgical precision in oncology. Its proprietary EnVisio® System offers real-time, continuous 3D surgical awareness, enabling surgeons to locate and target tumors with unparalleled accuracy. The platform synchronizes depth, distance, and direction data, providing cutting-edge guidance that improves outcomes in tumor resection procedures. Founded in 2015, the company targets the intersection of medical devices and oncology, aiming to reduce incomplete resections and improve patient survival. While specific funding and valuation details are undisclosed, Elucent's technology addresses a critical need in cancer surgery, positioning it for potential growth as it seeks to commercialize its platform and expand into additional clinical indications.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for Next-Generation EnVisio System70% success
• Q4 2026Strategic Partnership or Distribution Agreement with Major Surgical Equipment Manufacturer40% success
• Q2 2026Publication of Pivotal Clinical Trial Results Demonstrating Superiority Over Standard of Care60% success